Why is Grindr (GRND) paying $250m for Freddie?

Sonal Goyal

28 October 2026 05:40 PM AEDT

Why is Grindr (GRND) paying $250m for Freddie?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Grindr will acquire PurposeMed, parent of telehealth provider Freddie, for $250 million, with up to $70 million more tied to 2027 targets.
Freddie expects 2026 Revenue above $80 million and adjusted EBITDA above $10 million, according to the announcement.
Grindr reported second-quarter 2026 revenue of $138 million and adjusted EBITDA of $58 million, and raised its full-year guidance.

The Freddie acquisition

Grindr Inc. (NYSE:GRND) announced on 30 September 2026 that it will acquire PurposeMed Inc., the Parent Company of Freddie, a telehealth provider of PrEP and HIV prevention care. The price is $250 million, made up of $190 million in cash and $60 million in Grindr common stock, with up to a further $70 million of cash tied to 2027 performance targets and payable in 2028.

Both boards have approved the deal, which is expected to close in the fourth quarter of 2026 subject to closing conditions. The announcement described the cash and stock components but did not say how the cash portion would be funded.

What Freddie brings

According to the announcement, Freddie was founded in Canada in 2020, has served more than 55,000 patients and now serves patients in all 50 US states. It expects 2026 revenue above $80 million and adjusted EBITDA above $10 million. Those are the target's own expectations, not audited results.

Grindr said it expects an immaterial effect on its 2026 results and will give more detail on its 2027 outlook on its third-quarter Earnings Call in November.

Several comparisons follow from the disclosed numbers. The base price equates to roughly 3 times Freddie's expected 2026 revenue. If the earn-out were paid in full, total consideration would reach up to $320 million. A larger telehealth Business could therefore dilute group margins over time, although the company has not given Margin guidance for 2027.

Latest reported results

Grindr reported second-quarter 2026 results on 6 August 2026. Revenue was $138 million and adjusted EBITDA was $58 million, up from $45 million a year earlier, which corresponds to an adjusted EBITDA margin of about 42 per cent.

The company raised its full-year 2026 revenue and adjusted EBITDA guidance. The revenue expectation is approximately $540 million and adjusted EBITDA approximately $232 million. These are forecasts, not reported results.

What to watch

Grindr will release third-quarter 2026 results after the market closes on Thursday 5 November 2026, with a call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time), according to a company notice.

Points to follow include the 2027 outlook including Freddie, the funding of the cash consideration, regulatory and closing progress, and how a telehealth business fits alongside the existing app. Revenue growth, margin and user metrics will also be part of the update, and whether the deal remains on track for the fourth quarter is a useful marker.

FAQs

Q: How much is Grindr paying for Freddie?

A: The price is $250 million, made up of $190 million in cash and $60 million in Grindr stock, plus up to $70 million of cash tied to 2027 performance targets and payable in 2028.

Q: When is the Freddie deal expected to close?

A: Both boards have approved it, and closing is expected in the fourth quarter of 2026, subject to closing conditions.

Q: When does Grindr report third-quarter results?

A: Grindr will report after the market closes on 5 November 2026, with a call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.